Literature DB >> 2171734

The absorption of tricalcium phosphate and its acute metabolic effects.

R Shires1, G M Kessler.   

Abstract

The use of calcium (Ca) supplements by postmenopausal women is growing rapidly. A commercial preparation of tricalcium phosphate (TCP) is available in the USA. Depending on the relative absorption of Ca versus phosphate, a rise in serum phosphorus (P) could stimulate parathyroid hormone (iPTH) secretion. We therefore compared Ca absorption and the metabolic responses following TCP to that of Ca carbonate (CC) on separate occasions in each of 10 women, aged 22-40 years. The subjects were fasted overnight for 12 hours while good hydration was maintained. Following a 2-hour baseline-urine collection, 1200 mg calcium (as CC or TCP) was ingested and two 2-hour postload urine collections were made. Blood was drawn at 1, 2, and 4 hours after the Ca load. Serum (S) and urine (U) Ca, P, and creatinine, and U cyclic AMP (cAMP) were determined. iPTH levels following TCP were also measured. Ca absorption was determined by the postload rise in Uca above baseline. Uca excretion increased significantly and was accompanied by significant rises in Sca after both preparations. Following TCP, S and U phosphorus increased. Urinary cAMP did not change after either preparation, and iPTH levels fell after oral TCP. We conclude that Ca taken as TCP is absorbed adequately and, thus, despite a rise in the S phosphorus level does not stimulate parathyroid activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2171734     DOI: 10.1007/BF02555978

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  9 in total

1.  Calcium and phosphorus dynamics in pregnancy.

Authors:  C KERR; H F LOKEN; M B GLENDENING; G S GORDAN; E W PAGE
Journal:  Am J Obstet Gynecol       Date:  1962-01-01       Impact factor: 8.661

2.  A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias.

Authors:  C Y Pak; R Kaplan; H Bone; J Townsend; O Waters
Journal:  N Engl J Med       Date:  1975-03-06       Impact factor: 91.245

3.  Metabolism in immunoreactive parathyroid hormone in the dog. The role of the kidney and the effects of chronic renal disease.

Authors:  K A Hruska; R Kopelman; W E Rutherford; S Klahr; E Slatopolsky; A Greenwalt; T Bascom; J Markham
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

4.  Calcium bioavailability.

Authors:  R P Heaney
Journal:  Bol Asoc Med P R       Date:  1987-01

5.  Research directions in osteoporosis.

Authors:  W A Peck; B L Riggs; N H Bell; R B Wallace; C C Johnston; S L Gordon; L E Shulman
Journal:  Am J Med       Date:  1988-02       Impact factor: 4.965

6.  The role of phosphate in the secretion of parathyroid hormone in man.

Authors:  E Reiss; J M Canterbury; M A Bercovitz; E L Kaplan
Journal:  J Clin Invest       Date:  1970-11       Impact factor: 14.808

7.  Pathophysiological studies in idiopathic hypercalciuria: use of an oral calcium tolerance test to characterize distinctive hypercalciuric subgroups.

Authors:  A E Broadus; M Dominguez; F C Bartter
Journal:  J Clin Endocrinol Metab       Date:  1978-10       Impact factor: 5.958

8.  Calcium bioavailability from calcium carbonate and calcium citrate.

Authors:  M J Nicar; C Y Pak
Journal:  J Clin Endocrinol Metab       Date:  1985-08       Impact factor: 5.958

9.  The acute biochemical effects of four proprietary calcium preparations.

Authors:  I R Reid; B A Schooler; S F Hannan; H K Ibbertson
Journal:  Aust N Z J Med       Date:  1986-04
  9 in total
  5 in total

1.  Acute biochemical variations induced by four different calcium salts in healthy male volunteers.

Authors:  J Y Reginster; D Denis; V Bartsch; R Deroisy; B Zegels; P Franchimont
Journal:  Osteoporos Int       Date:  1993-09       Impact factor: 4.507

2.  What is hypercalcemia? The importance of fasting samples.

Authors:  Fadi F Siyam; David M Klachko
Journal:  Cardiorenal Med       Date:  2013-10-18       Impact factor: 2.041

3.  The acute metabolic effects of oral tricalcium phosphate and calcium carbonate.

Authors:  R S Yang; T K Liu; K S Tsai
Journal:  Calcif Tissue Int       Date:  1994-11       Impact factor: 4.333

4.  Fabrication and evaluation of porous beta-tricalcium phosphate/hydroxyapatite (60/40) composite as a bone graft extender using rat calvarial bone defect model.

Authors:  Jae Hyup Lee; Mi Young Ryu; Hae-Ri Baek; Kyung Mee Lee; Jun-Hyuk Seo; Hyun-Kyung Lee
Journal:  ScientificWorldJournal       Date:  2013-12-17

5.  Postprandial effects of calcium phosphate supplementation on plasma concentration-double-blind, placebo-controlled cross-over human study.

Authors:  Ulrike Trautvetter; Michael Kiehntopf; Gerhard Jahreis
Journal:  Nutr J       Date:  2013-03-08       Impact factor: 3.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.